Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational studyArticle Published on 2022-10-012022-11-15 Journal: Breast cancer research and treatment [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] Affect Breast Breast cancer breast cancer patient breast cancer patients Cancer cancer treatment CDK4/6 Chemotherapy collected COVID-19 Efficacy enrolled epidermal first vaccination five group growth factor Infection Infection prevention inhibitor inhibitors investigated Japan lowest neutralizing antibody Neutralizing antibody titer Omicron variant pandemic Patient Prevent prospective observational study raising receptor reduction reduction in SARA-CoV-2 SARS-CoV-2 vaccination SARS-CoV-2 variant second vaccination Seroconversion seroconversion rate serological response serum sample stratified suggested Support the patient the SARS-CoV-2 therapy Treatment vaccination vaccination efficacy Vaccine variant wild-type [DOI] 10.1007/s10549-022-06693-2 PMC 바로가기
High recurrence of lymphedema and influencing factors in discharged breast cancer patients during the COVID-19 pandemic: A multicenter, cross-sectional surveyArticle Published on 2022-10-012022-11-16 Journal: Cancer Medicine [Category] COVID19(2023년), SARS, 치료기술, [키워드] 95% confidence interval Analysis Anxiety Breast cancer breast cancer patient caused Characteristics Complete conducted coronavirus disease COVID-19 COVID-19 pandemic cross-sectional cross-sectional survey Depression difference discharged effort eight elevated Factor feasible groups Guidance hospital identify increased risk information lockdown Logistic regression lymphedema management Mild moderate multicenter multivariable Multivariable regression norman Questionnaire. Odds ratio Older age Pain pandemic Patient patients performed preference Prevalence pros Psychological distress quarantine Radiotherapy reported risk self-care Self-management Symptom the patient Treatment was used while Wuhan, China [DOI] 10.1002/cam4.4737 PMC 바로가기
Radiation recall dermatitis induced by COVID-19 vaccination in breast cancer patients treated with postoperative radiation therapyResearch article Published on 2022-10-012022-10-05 Journal: Breast (Edinburgh, Scotland) [Category] 바이오마커, [키워드] Administered administration adverse event analyzed Anti-inflammatory drugs Breast Breast cancer breast cancer patient breast cancer patients Case report Cohort counseling Course COVID-19 vaccination dose evaluated Factor first dose higher risk incidence investigated local symptom Patient patients postoperative potential risk questionnaire Radiation Radiation recall dermatitis radiation therapy recall reported required Result scored severity single dose Symptom therapy treated vaccination Vaccine [DOI] 10.1016/j.breast.2022.06.008 [Article Type] Research article
Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modalityResearch article Published on 2022-07-012022-10-05 Journal: European Journal of Radiology [Category] 진단, [키워드] 18F-FDGfluorodexoyglucose Axillary Lymphadenopathy Breast cancer breast cancer patient characteristic Characteristics clinical information cN+patients with suspicious axillary lymph node findings cN0patients without suspicious axillary lymph node findings cortical COVID-19 COVID-19 vaccination current Diagnosis diagnostic distribution Evidence Factor fatty fluorodexoyglucose Frequency IMPROVE injection Interpretation ipsilateral Lymph node magnetic resonance imaging MRI MRImagnetic resonance imaging mRNA patients with suspicious axillary lymph node findings patients without suspicious axillary lymph node findings PET/CT PET/CTpositron emission tomography / computed tomography Pneumonia positron emission tomography / computed tomography post-COVID-19 vaccination provide reported Result selected suggested Treatment Ultrasound USultrasound vaccination Vaccine vaccine dose was performed women [DOI] 10.1016/j.ejrad.2022.110334 [Article Type] Research article
Risk and severity of SARS-CoV-2 infection in breast cancer patients undergoing a structured infection screening program at the University and Hospital Trust of VeronaUniversity and Hospital Trust of Verona에서 구조화된 감염 선별 검사 프로그램을 받는 유방암 환자의 SARS-CoV-2 감염 위험 및 중증도Article Published on 2022-06-012022-09-11 Journal: Annals of oncology : official journal of the Europ [Category] COVID19(2023년), SARS, 치료기술, [키워드] breast cancer patient Infection SARS-COV-2 infection severity Trust university Verona [DOI] 10.1016/j.annonc.2022.02.227 PMC 바로가기 [Article Type] Article
Ultra-Hypofractionated vs. Moderate Fractionated Whole Breast Three Dimensional Conformal Radiotherapy during the COVID-19 PandemicRandomized Controlled Trial Published on 2022-05-302022-10-05 Journal: Medicina [Category] COVID19(2023년), SARS, 임상, [키워드] addition analyzed application Breast Breast cancer breast cancer patient breast cancer patients comparable Compliance cosmetic COVID COVID-19 COVID-19 outbreak COVID-19 pandemic CTCAE descending dose fraction Grade 1 infected case ipsilateral lung material median moderate objective outbreak pandemic parameters Patient patients with moderate Prevalence Radiation Radiation dose Radiotherapy randomized study reducing regimen risk SARS-CoV-2 Scoring significantly lower Still tissue Toxicity Treatment ultra-hypofractionated radiotherapy. [DOI] 10.3390/medicina58060745 PMC 바로가기 [Article Type] Randomized Controlled Trial
A Cohort Study on the Immunogenicity and Safety of the Inactivated SARS-CoV-2 Vaccine (BBIBP-CorV) in Patients With Breast Cancer; Does Trastuzumab Interfere With the Outcome?유방암 환자에서 비활성화된 SARS-CoV-2 백신(BBIBP-CorV)의 면역원성과 안전성에 대한 코호트 연구; Trastuzumab이 결과를 방해합니까?Article Published on 2022-03-012022-09-12 Journal: Frontiers in Endocrinology [Category] MERS, SARS, 진단, [키워드] Adverse age Anti-RBD IgG antibody BBIBP-CorV Breast Breast cancer breast cancer patient Cancer cohort study Common Terminology Criteria COVID-19 COVID-19 infection COVID-19 vaccine determine dose effective Efficacy and safety ELISA Fever follow-up period IgG immunogenicity inactivated Inactivated SARS-CoV-2 vaccine Infection injection site pain Iran Local malignancy multi Patient patients PCR prevalence of COVID-19 Prevent RBD IgG Safety SARS-CoV-2 SARS-CoV-2 anti-spike IgG SARS-CoV-2 vaccine SARS-CoV2 Seroconversion Side effects systemic side-effect the SARS-CoV-2 tolerable Trastuzumab vaccination were assessed were used [DOI] 10.3389/fendo.2022.798975 PMC 바로가기 [Article Type] Article
On top of that all, now Covid-19, too. A scoping review of specificities and correlates of fear of cancer recurrence in breast cancer patients during COVID-19 ☆Review Published on 2022-02-102022-10-28 Journal: Breast (Edinburgh, Scotland) [Category] COVID-19, COVID19(2023년), Fulltext, MERS, SARS, [키워드] Anxiety Breast cancer breast cancer patient breast cancer patients Cancer cancer diagnosis changes in COVID-19 COVID-19 pandemic criteria Depression distress elevated exacerbate Factor fear Fear of cancer progression fear of cancer recurrence Follow-up impair indicated Isolation medical system methodological methodology pandemic Pathologies Patient patients prevalent PTSD Quality of life Quantitative reaction reported Risk factors specificity subject survivor Symptoms Topic Treatment [DOI] 10.1016/j.breast.2022.02.007 PMC 바로가기 [Article Type] Review
The effects of the COVID-19 pandemic on psychological stress in breast cancer patientsResearch Published on 2021-12-312022-10-28 Journal: BMC Cancer [Category] COVID-19, [키워드] “COVID-19 affected age Breast cancer breast cancer patient breast cancer patients caused Comprehensive coping COVID-19 COVID-19 infection COVID-19 pandemic defined demographic factor demonstrated Diagnosis distress Effect European help highest identify Intensive inventory majority not differ organization pandemic parameter participant Patient Psychological Psychological distress psychological health psychological support psychologically questionnaire receiving recruited reported Result SARS-CoV-2 screened significant effect significantly Stress subgroup subpopulation subsequent supplementary material susceptible Symptoms therapeutic therapy Thermometer [DOI] 10.1186/s12885-021-09012-y PMC 바로가기 [Article Type] Research
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitorsCDK4/6 억제제를 투여받는 유방암 환자의 첫 번째 백신 접종 후 SARS-CoV-2 중화 항체Article Published on 2021-12-012022-09-12 Journal: Breast (Edinburgh, Scotland) [Category] MERS, SARS, 진단, [키워드] Analysis benefit Breast Breast cancer breast cancer patient cancer patient CDK4/6 inhibitors COVID-19 COVID-19 vaccine Critical dose Efficacy and safety first dose first vaccination General population healthy controls immune response inhibitor inhibitors initial neutralizing antibody pandemic post vaccination Protective raised receiving reduce SARS-CoV-2 immunity SARS-CoV-2 neutralizing antibody Treatment vaccination [DOI] 10.1016/j.breast.2021.08.017 PMC 바로가기 [Article Type] Article